Related Experiment Video
Updated: Mar 6, 2026

Minimally Invasive Thumb-sized Pterional Craniotomy for Surgical Clip Ligation of Unruptured Anterior Circulation Aneurysms
Published on: August 11, 2015
Tenzingplasty for symptomatic, non-occlusive intracranial atherosclerotic disease after maximal medical therapy
Faraz Behzadi1, Cameron M McDougall2, Neehar Gaddam3
1Department of Neurology; University of Arizona College of Medicine, Phoenix, US.
Insights
The Tenzing angioplasty technique (T-Plasty) offers a safe and effective option for treating intracranial atherosclerotic disease (ICAD) without large vessel occlusion (LVO), improving patient outcomes and reducing stroke severity.
Area of Science:
- Neurology
- Interventional Neuroradiology
- Vascular Surgery
Background:
- Intracranial atherosclerotic disease (ICAD) is a significant cause of ischemic stroke.
- Traditional balloon angioplasty for ICAD carries a high complication rate.
- The Tenzing support catheter, initially designed for large vessel occlusion (LVO) stroke, shows potential for ICAD treatment.
Purpose of the Study:
- To evaluate the safety and efficacy of the Tenzing angioplasty technique (T-Plasty) for treating ICAD in the absence of LVO.
- To assess neurological outcome improvements and complication rates associated with T-Plasty for ICAD.
Main Methods:
- A prospectively maintained database of adult ICAD patients without LVO treated with T-Plasty was reviewed.
- Data collected included demographics, procedural details, and clinical outcomes using NIHSS and mRS.
- Statistical analysis, including Student's T-test, was employed to assess significance.
Main Results:
- 18 adult patients with symptomatic ICAD (no LVO) underwent T-Plasty between September 2024 and April 2025.
- All patients demonstrated improvement, with an average NIHSS reduction of 4.5 points and mRS improvement of nearly 1 point.
- No operative or post-operative complications were observed within 30-day follow-up.
Conclusions:
- T-Plasty is a viable option for the elective treatment of chronic symptomatic ICAD.
- This technique can also be beneficial for acute hypoperfusion syndrome secondary to ICAD.
- T-Plasty demonstrates potential for improving neurological outcomes in ICAD patients.
Objective:
Intracranial atherosclerotic disease (ICAD) is an important cause of ischemic stroke. Balloon angioplasty for ICAD with or without a stent is associated with a high complication rate. The Tenzing support catheter (Route92 Medical) is a tapering offset catheter designed for improving aspiration catheter delivery in large vessel occlusion ischemic stroke (LVO). In LVO secondary to ICAD, we noted that the Tenzing could be used for angioplasty. In this study, we report our experience with the Tenzing angioplasty technique (T-Plasty) for ICAD treatment in the absence of LVO.
Methods:
A prospectively maintained database of all adult ICAD patients without LVO treated with T-Plasty at our institution was reviewed. Information on demographics, procedural details, clinical outcomes, and complications is reported here based on the National Institute of Health Stroke Scale (NIHSS) and the modified Rankin Scale (mRS). Student's T-test was applied to evaluate for statistical significance when appropriate.
Results:
From September 2024 to April 2025, 18 adult patients underwent T-Plasty for symptomatic ICAD without LVO. All patients experienced an improvement; the early cohort had a 4.5 points reduction in NIHSS immediate post T-Plasty, and both the elective and early cohorts experienced close to 1 point improvement in baseline mRS. No operative or post-operative related complications were noted up to 30-day follow-up.
Conclusions:
T-Plasty for the elective treatment of chronic symptomatic ICAD and acute hypoperfusion syndrome is an option for improving neurologic outcome.
Related Concept Videos
Aneurysm III: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Atherosclerosis III: Management
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Coronary Artery Disease V: Interprofessional Care

